Correlation Between Iridium Communications and Teva Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Iridium Communications and Teva Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iridium Communications and Teva Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Iridium Communications and Teva Pharmaceutical Industries, you can compare the effects of market volatilities on Iridium Communications and Teva Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iridium Communications with a short position of Teva Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iridium Communications and Teva Pharmaceutical.

Diversification Opportunities for Iridium Communications and Teva Pharmaceutical

0.15

Correlation Coefficient

Iridium Communications  Teva Pharmaceutical

Average diversification

The 3 months correlation between Iridium and Teva is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Iridium Communications and Teva Pharmaceutical Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Teva Pharmaceutical and Iridium Communications is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iridium Communications are associated (or correlated) with Teva Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Teva Pharmaceutical has no effect on the direction of Iridium Communications i.e., Iridium Communications and Teva Pharmaceutical go up and down completely randomly.

Pair Corralation between Iridium Communications and Teva Pharmaceutical

Assuming the 90 days horizon Iridium Communications is expected to under-perform the Teva Pharmaceutical. But the stock apears to be less risky and, when comparing its historical volatility, Iridium Communications is 1.2 times less risky than Teva Pharmaceutical. The stock trades about -0.04 of its potential returns per unit of risk. The Teva Pharmaceutical Industries is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  1,035  in Teva Pharmaceutical Industries on October 4, 2024 and sell it today you would earn a total of  1,105  from holding Teva Pharmaceutical Industries or generate 106.76% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Iridium Communications  vs.  Teva Pharmaceutical Industries

Iridium Communications

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Iridium Communications has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Iridium Communications is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Teva Pharmaceutical

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Teva Pharmaceutical Industries are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Teva Pharmaceutical reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Iridium Communications and Teva Pharmaceutical

The main advantage of trading using opposite Iridium Communications and Teva Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iridium Communications position performs unexpectedly, Teva Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Teva Pharmaceutical will offset losses from the drop in Teva Pharmaceutical's long position.

The idea behind Iridium Communications and Teva Pharmaceutical Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.